(Q30333233)

18 June 2017

1 reference

title

Promising candidates for the treatment of chronic hepatitis C. (English)

1 reference

18 June 2017

1 reference

Michelle P Walker

1

1 reference

18 June 2017

Nanhua Yao

series ordinal

2

1 reference

18 June 2017

Zhi Hong

series ordinal

3

1 reference

18 June 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Expert Opinion on Investigational Drugs

18 June 2017

1 reference

18 June 2017

12

1 reference

18 June 2017

8

1 reference

18 June 2017

1269-1280

1 reference

The epidemiology and prevention of hepatocellular carcinoma

18 June 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

The association between hepatitis C infection and survival after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Determination of interferon-alpha2 allele composition in the genomic DNA from healthy volunteers and leukemic patients in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Pegylated interferons for the treatment of chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Binding of hepatitis C virus to CD81

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

In search of hepatitis C virus receptor(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Mechanism of ribosome recruitment by hepatitis C IRES RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Structures of two RNA domains essential for hepatitis C virus internal ribosome entry site function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Hepatitis C virus internal ribosome entry site-mediated translation is stimulated by specific interaction of independent regions of human La autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Two proteinase activities in HCV polypeptide expressed in insect cells using baculovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

A second hepatitis C virus-encoded proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Subcellular Localization and Topology of the p7 Polypeptide of Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Recent developments in the discovery of hepatitis C virus serine protease inhibitors--towards a new class of antiviral agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

HCV RNA-dependent RNA polymerase as a target for antiviral development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Reconstitution of hepatitis C virus protease activities in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

A collaborative screening program for the discovery of inhibitors of HCV NS2/3 cis-cleaving protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

The design of potent, non-peptidic inhibitors of hepatitis C protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Complex formation between the hepatitis C virus serine protease and a synthetic NS4A cofactor peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Product inhibition of the hepatitis C virus NS3 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Effect of alpha interferon on the hepatitis C virus replicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Solid-phase synthesis of peptidomimetic inhibitors for the hepatitis C virus NS3 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Persistence of YMDD variants after withdrawal of Lamivudine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

A mechanism for initiating RNA-dependent RNA polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Terminal nucleotidyl transferase activity of recombinant Flaviviridae RNA-dependent RNA polymerases: implication for viral RNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Activation and deactivation of a broad-spectrum antiviral drug by a single enzyme: adenosine deaminase catalyzes two consecutive deamination reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: divergence over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1269

10.1517/13543784.12.8.1269

21 January 2018

Identifiers

DOI

1 reference

18 June 2017

1 reference